Original ResearchA Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients
Section snippets
General Principles of Immunizations in Transplant Recipients
Vaccine-preventable diseases, such as influenza and pneumococcal disease, still cause considerable morbidity and mortality in solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) recipients. Although national and international guidelines advocate a systematic approach to pre- and post-transplantation immunizations in SOT and post-transplantation re-immunizations in HSCT recipients,1, 2, 3, 4, 5 wide variations in immunization practices6 and deviations from guidelines
Immunizations in Solid Organ Transplantation Candidates
Solid organ transplantation candidates are more likely to develop vaccine-induced immunity compared with SOT recipients receiving immunosuppressive agents. Physicians who provide care to potential transplantation candidates should vaccinate them in accordance with published guidelines as early as possible in the course of their end-stage organ disease.1, 2, 5 The pretransplantation evaluation is a convenient time to review immunization records and initiate these immunizations,1, 2, 5 guided by
Immunizations in Solid Organ Transplant Recipients
Immunizations after transplantation may be variably immunogenic but are still important in providing a measure of protection against vaccine-preventable diseases. There is emerging literature on the use of post-transplantation hepatitis B vaccine, with or without adjuvants, to shorten the duration of hepatitis B immunoglobulin after liver transplantation for hepatitis B, but this issue is outside the scope of the present review. This review will summarize the most common immunizations given
Lack of Association between Immunizations and Allograft Rejection
Influenza immunizations had been withheld in the past due to the fear of triggering allograft rejection, based on case reports and small case series. However, larger studies have failed to support any clinically relevant association between immunizations and rejection or allograft dysfunction.12, 37, 38 The evidence from these studies is summarized and only a few examples will be cited herein. A large multicenter study of more than 5000 patients in 28 heart transplantation programs that had a
Immunizations in Hematopoietic Stem Cell Transplant Recipients
In HSCT recipients, post-transplantation immune recovery begins with engraftment of neutrophils, but lymphocyte recovery is a prolonged process. Reconstitution of the immune system requires at least several months post-transplantation, and some patients continue to have immune deficits for several years after HSCT. Thus, much of previous donor and recipient immunity to specific pathogens is lost, and HSCT programs generally carry out a comprehensive post-transplantation revaccination program.
Background
Live attenuated vaccines (Table IV) are generally contraindicated in SOT and HSCT recipients due to the theoretical risk of vaccine-acquired infections. However, transplant recipients are at increased risk for developing severe or disseminated forms of infectious diseases from wild-type pathogens and, given that there are growing safety profile and effectiveness data for select live attenuated vaccines in transplant recipients, we will review new developments for each live attenuated vaccine
Immunizations for Transplant Recipients Planning Travel
When transplant recipients are planning international travel, both clinicians and patients should be familiar with the American Society of Transplantation Infectious Diseases Guidelines for travel70 and other similar guidelines. For international travel, especially to countries or areas with suboptimal sanitation, it is preferable to wait until 1 year after transplantation, although for some patients it may be advisable to wait longer (eg, if they are experiencing organ rejection or infections
Immunizations for Household Contacts of Transplant Recipients
Household contacts of transplant recipients should receive immunizations, whether live attenuated or inactivated, as indicated for the general public (Table IV). Avoidance of recently immunized household contacts by transplant recipients is not evidence-based and is unnecessary. The IDSA Guidelines also state that the live travel-related vaccines (YF, oral typhoid) may be administered to household contacts.2 Among vaccines administered to the general public, the only vaccine for which household
Conclusions
Immunizations remain underutilized in transplantation candidates, transplant recipients, and household contacts. Vaccine-preventable diseases, particularly influenza, varicella, HZ, and invasive pneumococcal infections, continue to cause considerable morbidity and mortality in SOT and HSCT recipients. More systematized protocols and more vigorous endorsements of immunization programs are needed. Non-live vaccines are tolerable for transplantation candidates and transplant recipients.
Conflicts of Interest
P.P.C and R.K.A have no conflicts of interest to disclose.
Acknowledgment
P.P.C and R.K.A contributed to drafting the manuscript. Both authors critically revised and approved of the final version of the manuscript to be published.
References (70)
- et al.
Vaccination in solid organ transplantation
Am J Transplant
(2013) - et al.
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective
Biol Blood Marrow Transplant
(2009) - et al.
Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series
Vaccine
(2016) - et al.
Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination
Kidney Int
(2012) - et al.
Accelerated schedule of hepatitis B vaccination in liver transplant candidates
Transplant Proc
(1998) - et al.
HPV-related cancers after solid organ transplantation in the United States
Am J Transplant
(2013) - et al.
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Lancet
(2007) - et al.
Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients
Am J Transplant
(2013) - et al.
Invasive pneumococcal disease in solid organ transplant recipients--10-year prospective population surveillance
Am J Transplant
(2007) - et al.
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study
Lancet Infect Dis
(2010)
Influenza vaccination in the organ transplant recipient: review and summary recommendations
Am J Transplant
Improving clinical practice: should we give influenza vaccinations to heart transplant patients?
J Heart Lung Transplant
Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic
Am J Transplant
Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients
Am J Transplant
Varicella infection following varicella vaccination in a liver transplant recipient
Am J Transplant
Herpes zoster at the NIH: a 20 year experience
Am J Med
Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study
Blood
Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients
Biol Blood Marrow Transplant
Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation
Vaccine
Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients
Vaccine
Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation
Am J Transplant
Persistent seropositivity for yellow fever in a previously vaccinated autologous hematopoietic stem cell transplantation recipient
Int J Infect Dis
Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS)
Vaccine
Travel medicine and transplant tourism in solid organ transplantation
Am J Transplant
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host
Clin Infect Dis
Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients
Clin Infect Dis
Post-hematopoietic stem cell transplant immunization practices in the Pediatric Blood and Marrow Transplant Consortium
Pediatr Blood Cancer
Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice
Transpl Infect Dis
Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
Infection
Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series
BMJ Open
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe
Clin Microbiol Infect
Outcomes associated with influenza vaccination in the first year after kidney transplantation
Clin J Am Soc Nephrol
Influenza vaccination and humoral alloimmunity in solid organ transplant recipients
Transpl Int
Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs
Clin Transplant
Cited by (87)
Disseminated varicella with systemic implications in a renal transplant recipient
2023, Anais Brasileiros de DermatologiaCOVID-19 and severity of liver diseases: Possible crosstalk and clinical implications
2023, International ImmunopharmacologyCoronavirus Disease-2019 and Implications on the Liver
2023, Clinics in Liver DiseaseCitation Excerpt :Data on COVID-19 immunization in LT recipients have shown the vaccines to be safe and effective at preventing hospitalization and death.63 Available data do not show an increased risk of alloimmunity and graft rejection.70 It is important to note that none of the available vaccines contain live SARS-CoV-2; therefore, replication of SARS-CoV-2 after vaccination is not possible even in immunocompromised patients.
Management of kidney transplant recipients for primary care practitioners
2024, BMC NephrologyParent caregivers’ preferences and satisfaction with currently provided childhood cancer survivorship care
2024, Journal of Cancer Survivorship